|
|||||
|
|
Effect of smoking status on progression‐free and overall survival in non‐small cell lung cancer patients receiving erlotinib or gefitinib: a meta‐analysis |
|
| Authors: | H. S. Sohn PhD J.‐W. Kwon PhD S. Shin PharmD H.‐S. Kim MD PhD H. Kim PharmD BCPS |
| Affiliation: | 1. Graduate School of Clinical Pharmacy, CHA University, Gyeonggi‐do, Korea;2. College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, Korea;3. College of Pharmacy, Ajou University, Suwon, Korea;4. College of Medicine, The Catholic University of Korea, Seoul, Korea;5. College of Pharmacy, Sookmyung Women's University, Seoul, Korea |
| Abstract: | |
| Keywords: | erlotinib gefitinib non‐small cell lung cancer smoking |